Andrés JM Ferreri
IELSG · Ospedale San Raffaele s.r.l. · San Raffaele Scientific Institute, Milano, Italy
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Andrés JM Ferreri as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:04 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT02329080 · New Combination of Chemoimmunotherapy for Systemic B-cell Lymphoma With Central Nervous System InvolvementInternational Extranodal Lymphoma Study Group (IELSG) · completed · Diffuse Large B-cell Lymphoma · study chair
- Ph1NCT02017613 · Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in Hematological MalignanciesRhizen Pharmaceuticals SA · completed · Lymphoma, B-Cell, T-Cell Lymphoma · study chair
- Ph2NCT01516606 · Salvage Therapy With High Dose Oral Clarithromycin in Relapsed or Refractory Extranodal Marginal Zone LymphomaAndres J. M. Ferreri · completed · Lymphoma · study chair
- Ph2NCT01516619 · Secondary Prophylaxis in Non-Hodgkin Lymphoma (NHL) and Chemotherapy-induced ThrombocytopeniaAndres J. M. Ferreri · completed · Non-Hodgkin Lymphoma · study chair
- Ph2NCT01516593 · Short Term Intensified Chemo-immunotherapy in HIV-positive Patients With Burkitt LymphomaAndres J. M. Ferreri · completed · HIV, Burkitt's Lymphoma · study chair
- Ph2NCT01514344 · Intralesional Rituximab for the Treatment of Conjunctival Indolent LymphomaAndres J. M. Ferreri · completed · Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma · study chair
- Ph2NCT01011920 · Trial for Patients With Newly Diagnosed Primary Central Nervous System (CNS) LymphomaInternational Extranodal Lymphoma Study Group (IELSG) · completed · Central Nervous System Lymphoma · study chair
- Ph2NCT01010295 · A Clinico-Pathological Study to Investigate the Possible Infective Causes of Non-Hodgkin Lymphoma of the Ocular AdnexaeInternational Extranodal Lymphoma Study Group (IELSG) · completed · Non-Hodgkin Lymphoma · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:04 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 11:04 UTC. The ranking covers the 200 most relevant of 68 PubMed records, and a shared surname and initials can bring in a namesake. All 68 on PubMed
- 507 citationsRCR 19.1
- 500 citationsRCR 13.9
- Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial.Nat Med · 2022491 citationsRCR 31.6
- 318 citationsRCR 11.8
- Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type.Blood · 2003311 citationsRCR 7.5
- 183 citationsRCR 5.1
- Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy.J Clin Oncol · 2005181 citationsRCR 4.4
- 162 citationsRCR 6.2
- 162 citationsRCR 14.8
- Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy.J Clin Oncol · 2005159 citationsRCR 3.7